COVID vaccine heart inflammation symptom registry
Part of Heart & circulation clinical trials.
This study is a “registry,” meaning it collects medical information about people who develop possible heart inflammation after a COVID-19 vaccine. It may help doctors understand how often this happens and which findings are linked to it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were eligible to receive a COVID-19 vaccine (for the time period you got it).
- Your symptoms or test results happened within 42 days after a COVID-19 vaccine dose.
- You have at least one heart-related symptom after vaccination, or two general symptoms, or no symptoms but abnormal heart tests/images.
- Your case also matches at least one specific heart finding, such as abnormal troponin blood tests, abnormal MRI/ECG/echo, or signs of inflammation on tests.
- Your doctors have not found a clear alternative explanation for your symptoms/findings.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who may have developed myocarditis or pericarditis (inflammation of the heart muscle or the lining around the heart) shortly after a COVID-19 vaccine. It compares their health records to vaccination records to understand who is affected and when, which may help improve future care.
This study is collecting information from people who have had chest pain but no blockages in their heart arteries, to better understand a condition called myocarditis. Participating means allowing researchers to review your health records and possibly answer questions.
This study uses a special heart MRI to look closely at inflammation in the heart muscle. It helps doctors better understand and treat myocarditis and inflammatory cardiomyopathy.
This study looks at whether a simple blood test for troponin (a protein released when heart muscle is damaged) can help doctors predict how patients with acute myocarditis (heart muscle inflammation) will do over time. It may help guide follow-up care for people recovering from this condition.
This study uses heart scans (MRI or nuclear imaging) to better understand inflammatory heart conditions. If you have a suspected inflammatory heart disease and are already scheduled for one of these scans, you may be able to join.
This study looks at certain markers in your blood to better understand the risk level of myocarditis (inflammation of the heart muscle). It may help doctors know how to best monitor and treat your condition.
Hear when a new Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.